Concepedia

Verena Walter

VW

9

Publications

1.2K

Citations

9

H-Index

1994

Active since

Affiliations

Novartis (Switzerland)(Current)

Verena Walter is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and diabetes.

Top concepts

Publications per year

1994–2024

9

Publications

9

Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen

Paul M. Ridker, Campbell P. Howard, Verena Walter et al. · Circulation · 2012 · 524 citations · Full text

Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism.

Rose-Marie Bluthé, Verena Walter, Patricia Parnet et al. · PubMed · 1994 · 289 citations

, , +17

Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: Results of secondary endpoints from a randomized, placebo-controlled trial

J. Hensen, Campbell P. Howard, Verena Walter et al. · Diabetes & Metabolism · 2013 · 107 citations

, , +4

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia

Christine Manyando, Rhoda Mkandawire, Lwipa Puma et al. · Malaria Journal · 2010 · 67 citations · Full text

Testosterone-induced inhibition of spermatogenesis is more closely related to suppression of FSH than to testicular androgen levels in the cynomolgus monkey model (Macaca fascicularis)

GF Weinbauer, Stefan Schlatt, Verena Walter et al. · Journal of Endocrinology · 2001 · 64 citations · Full text

, , +21

Rows per page

1–5 of 9